Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases

GM Ren, J Li, XC Zhang, Y Wang, Y Xiao… - Science …, 2021 - science.org
Pharmacologically inhibiting nucleotide-binding domain and leucine-rich repeat-containing
(NLR) family, pyrin domain–containing protein 3 (NLRP3) inflammasome activation results …

RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor

Y Chen, H He, B Lin, Y Chen, X Deng… - Cellular & molecular …, 2021 - nature.com
The NLRP3 inflammasome plays a crucial role in innate immune-mediated inflammation
and contributes to the pathogenesis of multiple autoinflammatory, metabolic and …

Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets

L Vande Walle, M Lamkanfi - Nature Reviews Drug Discovery, 2024 - nature.com
Diseases associated with chronic inflammation constitute a major health burden across the
world. As central instigators of the inflammatory response to infection and tissue damage …

Modulatory mechanisms controlling the NLRP3 inflammasome in inflammation: recent developments

M Haneklaus, LAJ O'Neill, RC Coll - Current opinion in immunology, 2013 - Elsevier
The protein NLRP3 has emerged as a central regulator in the inflammatory process, being
implicated directly in hereditary cryopyrinopathies, and indirectly in diseases such as gout …

Pharmacological inhibitors of the NLRP3 inflammasome

A Zahid, B Li, AJK Kombe, T Jin, J Tao - Frontiers in immunology, 2019 - frontiersin.org
Inflammasomes play a crucial role in innate immunity by serving as signaling platforms
which deal with a plethora of pathogenic products and cellular products associated with …

Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases

JK Seok, HC Kang, YY Cho, HS Lee, JY Lee - Archives of Pharmacal …, 2021 - Springer
Inflammasomes are cytosolic pattern recognition receptors that recognize pathogen-
associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs) …

Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation

U Ohto, Y Kamitsukasa, H Ishida… - Proceedings of the …, 2022 - National Acad Sciences
The nucleotide-binding oligomerization domain (NOD)-like receptor pyrin domain containing
3 (NLRP3) responds to a vast variety of stimuli, and activated NLRP3 forms an …

The NLRP3 inflammasome: contributions to inflammation-related diseases

Y Chen, X Ye, G Escames, W Lei, X Zhang, M Li… - Cellular & molecular …, 2023 - Springer
The NOD-like receptor protein 3 (NLRP3) inflammasome is a protein complex that regulates
innate immune responses by activating caspase-1 and the inflammatory cytokines …

NLRP3 ubiquitination—a new approach to target NLRP3 inflammasome activation

M Akther, ME Haque, J Park, TB Kang… - International Journal of …, 2021 - mdpi.com
In response to diverse pathogenic and danger signals, the cytosolic activation of the NLRP3
(NOD-, LRR-, and pyrin domain-containing (3)) inflammasome complex is a critical event in …

Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors

Y Yang, H Wang, M Kouadir, H Song, F Shi - Cell death & disease, 2019 - nature.com
The NLRP3 inflammasome is a multimeric protein complex that initiates an inflammatory
form of cell death and triggers the release of proinflammatory cytokines IL-1β and IL-18. The …